Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Value of AstraZeneca's immuno-oncology deal could top $500M
Value of AstraZeneca's immuno-oncology deal could top $500M
Value of AstraZeneca's immuno-oncology deal could top $500M
Submitted by
admin
on August 6, 2015 - 12:14pm
Source:
Bizjournals.com
News Tags:
AstraZeneca
immuno-oncology
Heptares Therapeutics
Headline:
Value of AstraZeneca's immuno-oncology deal could top $500M
Do Not Allow Advertisers to Use My Personal information
